Rocket Lab's Motiv Acquisition Offsets SpaceX Index Snub as HASTE Flight Looms

Rocket Lab boosts space systems with Motiv acquisition, but SpaceX's S&P 500 exclusion and insider sales temper gains ahead of HASTE mission and Neutron rocket debut.

Rocket Lab has added a new piece to its space systems puzzle with the acquisition of Motiv Space Systems, a specialist in robotic arms and propulsion technology that has flown on NASA Mars missions. The deal bolsters the company’s push to control more of the space value chain, from satellite components to complex orbital infrastructure, and arrives as the broader sector rides a wave of anticipation around SpaceX's upcoming IPO.

Yet the same SpaceX story that has lifted Rocket Lab's stock also delivered a jolt this week. S&P Dow Jones Indices denied SpaceX fast-track entry into the S&P 500, citing the company's GAAP profitability shortfall — a net loss of $4.94 billion in fiscal 2025. The decision disappointed investors who had counted on passive fund inflows if SpaceX joined the blue-chip index. Since Rocket Lab is widely traded as a liquid proxy for pure-play space exposure, the stock shed roughly 3% in pre-market trading Friday, sliding toward $115, well off its recent peak of $151.

The contrasting forces highlight the dual nature of Rocket Lab's market position. On one hand, the Motiv deal strengthens the Space Systems division that has been a primary growth engine, following earlier acquisitions like Geost and Mynaric. On the other, the SpaceX index snub reminds traders that the proxy trade can cut both ways. Even as SpaceX's IPO — set for June 12 at a price of $135, with a potential valuation of up to $2 trillion — fuels sector enthusiasm, the absence of immediate index inclusion tempers the rally.

Operationally, Rocket Lab's next major milestone arrives June 10 with the suborbital HASTE flight "Curveball" from Wallops Island, Virginia. The Hypersonic Accelerator Suborbital Test Electron mission targets defense customers and hypersonic testing, a revenue stream that diversifies beyond classic orbital launches. Stifel recently raised its price target on Rocket Lab to $132, citing the attractive margins of HASTE missions and the company's operational scaling.

The financials support the bullish case. First-quarter revenue climbed 63.4% year-over-year to $200.35 million, while the order backlog stood at approximately $2.22 billion. However, the stock remains volatile: over the past seven days it lost 16.40%, though it still shows a monthly gain of 41.70% and year-to-date advance of 57.85%. The relative strength index sits at 51.9, neutral territory, while the stock still trades 65.81% above its 200-day moving average.

Capital flows paint a mixed picture. On June 2, Eurizon Capital SGR S.p.A. added 43,471 shares worth roughly $3 million, signaling institutional confidence in the end-to-end business model. But insider sales of about $18.4 million over the past week — at a time when the stock has more than doubled year-to-date — temper the signal, even if such sales can have varied motives.

The longer-term narrative hinges on the Neutron rocket. After a tank test failure early this year, management holds to a first flight window in the fourth quarter of 2026. Five firm launch contracts are already in place. Until Neutron proves itself, Rocket Lab must deliver on two fronts simultaneously: near-term reliability with HASTE and long-term scalability with its next-generation launcher. The June 10 flight provides the next operational checkpoint, but it is Neutron that will ultimately determine whether the company can close the gap with SpaceX and justify its current valuation.